Skip Navigation
Skip to contents

Epidemiol Health : Epidemiology and Health

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
9 "Boyoung Park"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original article
Changes in metabolic syndrome and risk of breast and endometrial cancers according to menopause
Thi Xuan Mai Tran, Soyeoun Kim, Boyoung Park
Epidemiol Health. 2023;e2023049.   Published online May 1, 2023
DOI: https://doi.org/10.4178/epih.e2023049    [Accepted]
  • 329 View
  • 0 Download
AbstractAbstract
Abstract
Objectives
This study investigated how changes in metabolic syndrome (MetS) are associated with the subsequent risk of breast and endometrial cancer according to menopausal status.
Methods
This cohort study, using data from the National Health Insurance Service database, included women aged ≥40 years who underwent 2 biennial cancer screenings (2009–2010 and 2011–2012) and were followed up until 2020. Participants were grouped into MetS-free, MetS-recovery, MetS-development, and MetS-persistent groups. Menopausal status (premenopausal, perimenopausal, and postmenopausal) was assessed at 2 screenings. Cox proportional hazard regression was used to assess the association between MetS changes and cancer risk.
Results
In 3,031,980 women, breast and endometrial cancers were detected in 39,184 and 4,298, respectively. Compared with the MetS-free group, those who recovered, developed, or had persistent MetS showed an increased risk of breast cancer, with adjusted hazard ratios (aHRs) of 1.05, 1.05, and 1.11, respectively (p<0.005). MetS persistence was associated with an increased risk of breast cancer in postmenopausal women (aHR=1.12, 95% CI, 1.08–1.16) but not in premenopausal or perimenopausal women. MetS persistence was associated with an increased risk of endometrial cancer in premenopausal, perimenopausal, and postmenopausal women, with aHRs of 1.41 (95% CI, 1.17–1.70), 1.59 (95% CI, 1.19–2.12), and 1.47 (95% CI, 1.32–1.63), respectively.
Conclusions
Increased breast cancer risk was associated with recovered, developed, and persistent MetS in postmenopausal women. Meanwhile, increased endometrial cancer risk was found in obese women who recovered from MetS or persistently had MetS, regardless of menopausal status, when compared to MetS-free women.
Summary
Korean summary
Key Message
Erratum
Erratum: Trends in gastrointestinal infections before and during non-pharmaceutical interventions in Korea in comparison with the United States
Soyeoun Kim, Jinhyun Kim, Bo Youl Choi, Boyoung Park
Epidemiol Health. 2022;44:e2022011.E.   Published online December 31, 2022
DOI: https://doi.org/10.4178/epih.e2022011.E
Corrects: Epidemiol Health 2022;44:e2022011
  • 925 View
  • 95 Download
PDF
Abstract
Summary
Korean summary
Key Message
COVID-19: Brief Communication
Trends in gastrointestinal infections before and during non-pharmaceutical interventions in Korea in comparison with the United States
Soyeoun Kim, Jinhyun Kim, Bo Youl Choi, Boyoung Park
Epidemiol Health. 2022;44:e2022011.   Published online January 3, 2022
DOI: https://doi.org/10.4178/epih.e2022011
Correction in: Epidemiol Health 2022;44(0):e2022011.E
  • 7,026 View
  • 448 Download
  • 1 Citations
AbstractAbstract AbstractSummary PDF
Abstract
OBJECTIVES
This study examined how trends in the weekly frequencies of gastrointestinal infectious diseases changed before and during the coronavirus disease 2019 (COVID-19) pandemic in Korea, and compared them with the trends in the United States.
METHODS
We compared the weekly frequencies of gastrointestinal infectious diseases (16 bacterial and 6 viral diseases) in Korea during weeks 5-52 before and after COVID-19. In addition, the weekly frequencies of 5 gastrointestinal infectious diseases in the United States (data from the Centers for Disease Control and Prevention) that overlapped with those in Korea were compared.
RESULTS
The mean weekly number of total cases of gastrointestinal infectious diseases in Korea showed a significant decrease (from 522 before COVID-19 to 245 after COVID-19, p<0.01). Only bacterial gastrointestinal infectious diseases caused by Campylobacter increased significantly; other bacterial gastrointestinal infectious diseases showed either a decrease or no change. The incidence of all other viral diseases decreased. In the United States, the weekly numbers of Salmonella, Campylobacter, typhoid, shigellosis, and hepatitis A virus cases sharply decreased after the COVID-19 outbreak. The weekly case numbers of all viral diseases markedly decreased in both countries; however, bacterial gastrointestinal infectious diseases showed a different pattern.
CONCLUSIONS
The incidence of gastrointestinal infectious diseases decreased after the COVID-19 outbreak. In contrast, Campylobacter infections showed an increasing trend in Korea, but a decreasing trend in the United States. Further studies are needed to elucidate the different trends in bacterial and viral infectious diseases before and after non-pharmaceutical interventions and between different countries.
Summary
Korean summary
한국과 미국 모두 코로나-19 발생 이후 위장관 감염 질환의 발생은 감소하고 있습니다. 하지만, 미국과 달리 한국에서는 캄필로박터 감염은 증가 하고 있습니다. 이는 COVID-19이 발생한 이후 캄필로박터 감염의 열악한 통제의 가능성을 설명할 수 있습니다.
Key Message
The incidence of gastrointestinal infectious diseases decreased after the COVID-19 outbreak, however, campylobacter infections showed an increasing trend in Korea, unlike the United States, which could explain the poor control of Campylobacter.

Citations

Citations to this article as recorded by  
  • Impact of the COVID‐19 pandemic on the circulation of other pathogens in England
    Lauren J. Hayes, Hannah Uri, Denisa Bojkova, Jindrich Cinatl, Mark N. Wass, Martin Michaelis
    Journal of Medical Virology.2023;[Epub]     CrossRef
COVID-19: Brief Communication
Time-variant reproductive number of COVID-19 in Seoul, Korea
Seong-Geun Moon, Yeon-Kyung Kim, Woo-Sik Son, Jong-Hoon Kim, Jungsoon Choi, Baeg-Ju Na, Boyoung Park, Bo Youl Choi
Epidemiol Health. 2020;42:e2020047.   Published online June 28, 2020
DOI: https://doi.org/10.4178/epih.e2020047
  • 10,191 View
  • 318 Download
  • 2 Citations
AbstractAbstract AbstractSummary PDFSupplementary Material
Abstract
OBJECTIVES
To estimate time-variant reproductive number (Rt) of coronavirus disease 19 based on either number of daily confirmed cases or their onset date to monitor effectiveness of quarantine policies.
METHODS
Using number of daily confirmed cases from January 23, 2020 to March 22, 2020 and their symptom onset date from the official website of the Seoul Metropolitan Government and the district office, we calculated Rt using program R’s package “EpiEstim”. For asymptomatic cases, their symptom onset date was considered as -2, -1, 0, +1, and +2 days of confirmed date.
RESULTS
Based on the information of 313 confirmed cases, the epidemic curve was shaped like ‘propagated epidemic curve’. The daily Rt based on Rt_c peaked to 2.6 on February 20, 2020, then showed decreased trend and became <1.0 from March 3, 2020. Comparing both Rt from Rt_c and from the number of daily onset cases, we found that the pattern of changes was similar, although the variation of Rt was greater when using Rt_c. When we changed assumed onset date for asymptotic cases (-2 days to +2 days of the confirmed date), the results were comparable.
CONCLUSIONS
Rt can be estimated based on Rt_c which is available from daily report of the Korea Centers for Disease Control and Prevention. Estimation of Rt would be useful to continuously monitor the effectiveness of the quarantine policy at the city and province levels.
Summary
Korean summary
우리나라 전체와 각 시도별 일별 증상 발현자 수 또는 확진자 수를 이용하여 추정한 Rt로 방역정책의 효과를 국가 및 시도 수준에서 지속적으로 모니터링 할 필요가 있다.
Key Message

Citations

Citations to this article as recorded by  
  • Reproduction Factor Based Latent Epidemic Model Inference: A Data-Driven Approach Using COVID-19 Datasets
    Sujin Ahn, Minhae Kwon
    IEEE Journal of Biomedical and Health Informatics.2023; 27(3): 1259.     CrossRef
  • COVID-19 early-alert signals using human behavior alternative data
    Anasse Bari, Aashish Khubchandani, Junzhang Wang, Matthias Heymann, Megan Coffee
    Social Network Analysis and Mining.2021;[Epub]     CrossRef
Original Articles
Socioeconomic inequalities in obesity among Korean women aged 19-79 years: the 2016 Korean Study of Women’s Health-Related Issues
Eunji Choi, Ha Na Cho, Da Hea Seo, Boyoung Park, Sohee Park, Juhee Cho, Sue Kim, Yeong-Ran Park, Kui Son Choi, Yumie Rhee
Epidemiol Health. 2019;41:e2019005.   Published online February 13, 2019
DOI: https://doi.org/10.4178/epih.e2019005
  • 11,953 View
  • 269 Download
  • 5 Citations
AbstractAbstract AbstractSummary PDF
Abstract
OBJECTIVES
While the prevalence of obesity in Asian women has remained stagnant, studies of socioeconomic inequalities in obesity among Asian women are scarce. This study aimed to examine the recent prevalence of obesity in Korean women aged between 19 years and 79 years and to analyze socioeconomic inequalities in obesity.
METHODS
Data were derived from the 2016 Korean Study of Women’s Health-Related Issues. The chi-square test and logistic regression analysis were used to analyze the associations between socioeconomic factors and obesity using Asian standard body mass index (BMI) categories: low (<18.5 kg/m2 ), normal (18.5-22.9 kg/m2 ), overweight (23.0-24.9 kg/m2 ), and obese (≥25.0 kg/ m2 ). As inequality-specific indicators, the slope index of inequality (SII) and relative index of inequality (RII) were calculated, with adjustment for age and self-reported health status.
RESULTS
Korean women were classified into the following BMI categories: underweight (5.3%), normal weight (59.1%), overweight (21.2%), and obese (14.4%). The SII and RII revealed substantial inequalities in obesity in favor of more urbanized women (SII, 4.5; RII, 1.4) and against of women who were highly educated (SII, -16.7; RII, 0.3). Subgroup analysis revealed inequalities in obesity according to household income among younger women and according to urbanization among women aged 65-79 years.
CONCLUSIONS
Clear educational inequalities in obesity existed in Korean women. Reverse inequalities in urbanization were also apparent in older women. Developing strategies to address the multiple observed inequalities in obesity among Korean women may prove essential for effectively reducing the burden of this disease.
Summary
Korean summary
한국 성인 여성의 과체중 및 비만유병률은 서구여성에 비해 낮으며 2005년 이후 큰 변화 없이 약40%대로 일정하게 유지되어왔으나, 사회경제적불평등에 대한 연구는 체계적으로 이루어지지 않음. 경사불평등(Slope index of inequality)과 상대불평등(Relative index of inequality) 지표를 사용하여 비만유병률에서 발견되는 사회경제적불평등을 조사한 결과, 교육수준별 불평등이 유의하게 나타남. 19-44세의 젊은 여성층에서는 소득수준이 낮은 집단에, 65-79세의 노년기 여성층에서는 도시화된 지역에 사는 집단에 비만유병률이 치중되어있음.
Key Message

Citations

Citations to this article as recorded by  
  • Disparities in Obesity Rates among Adults: Analysis of 514 Districts in Indonesia
    Dumilah Ayuningtyas, Dian Kusuma, Vilda Amir, Dwi Hapsari Tjandrarini, Pramita Andarwati
    Nutrients.2022; 14(16): 3332.     CrossRef
  • Socioeconomic Disparities in Cardiovascular Health in South Korea
    Chi-Young Lee, Eun-Ok Im
    Journal of Cardiovascular Nursing.2021; 36(1): 8.     CrossRef
  • Incidence and risk of venous thromboembolism according to primary treatment in women with ovarian cancer: A retrospective cohort study
    Jin-Sung Yuk, Banghyun Lee, Kidong Kim, Myoung Hwan Kim, Yong-Soo Seo, Sung Ook Hwang, Sang-Hee Yoon, Yong Beom Kim, Wen-Chi Chou
    PLOS ONE.2021; 16(4): e0250723.     CrossRef
  • Regional Differences in Dietary Total Fat and Saturated Fatty Acid Intake and Their Associations with Metabolic Diseases among Korean Adults: Using the 2016~2019 Korea National Health and Nutrition Examination Surveys
    SuJin Song, Jae Eun Shim
    Korean Journal of Community Nutrition.2021; 26(6): 495.     CrossRef
  • Regional disparities in the associations of cardiometabolic risk factors and healthy dietary factors in Korean adults
    Kyungho Ha, YoonJu Song, Hye-Kyeong Kim
    Nutrition Research and Practice.2020; 14(5): 519.     CrossRef
Physician’s awareness of lung cancer screening and its related medical radiation exposure in Korea
Seri Hong, Suyeon Kim, Mina Suh, Boyoung Park, Kui Son Choi, Jae Kwan Jun
Epidemiol Health. 2018;40:e2018002.   Published online January 20, 2018
DOI: https://doi.org/10.4178/epih.e2018002
  • 11,906 View
  • 254 Download
  • 1 Citations
AbstractAbstract AbstractSummary PDFSupplementary Material
Abstract
OBJECTIVES
Through a survey on perception of lung cancer screening and accompanying medical radiation exposure in Korea, the present study was to investigate its current situations and evaluate various perception of physicians regarding it in order to propose measures for improvements.
METHODS
Medical specialists in national cancer screening institutions selected through stratified random sampling were subjected to face-to-face interview using a structured questionnaire. We investigated physicians’ perception on effectiveness of lung cancer screening depending on screening modality, selection criteria for subjects of screening, types of equipment used to screen, and perception for seriousness of adverse effects following the test. In addition, odds ratios to underestimate risk of radiation exposure from screening were calculated through logistic regression analysis.
RESULTS
Each response that chest X-ray is effective for lung cancer screening and that smoking history is not considered prior to screening recommendation accounted for more than 60% of respondents, suggesting the chance of unnecessary screening tests. Regarding adverse effects of lung cancer screening, about 85% of respondents replied that false positive, radiation exposure, and overdiagnosis could be ignored. About 70% of respondents underestimated radiation dose from lung cancer screening, and a low proportion of physicians informed patients of radiation exposure risk.
CONCLUSIONS
It was found that most physicians underestimated harms of lung cancer screening including radiation exposure and were lack of awareness regarding lung cancer screening. It should be noted that physicians need to have proper perceptions about screening recommendation and accompanying possible harms, for successful implementation of the screening program.
Summary
Korean summary
전국 100여개 국가암검진 기관을 대상으로 폐암검진 관련 설문을 수행한 결과, 효과적인 폐암검진의 수단이나 방법에 대한 이해 및 검사에 수반되는 각종 부작용에 대한 의사들의 인식이 확연히 부족한 것으로 조사되었다. 그 중에서도 특히 의료방사선 노출에 대한 낮은 인지도는, 촬영 시 피폭량에 대한 전반적인 과소평가 및 방사선 노출 위험과 관련한 환자 교육의 부재를 통해 확인할 수 있었다. 인구집단 대상 선별검사의 도입에 따른 잠재적인 위해 가능성과 그 결과에 대한 고민은 반드시 필요하며, 이와 관련된 의료제공자들의 인식 개선을 촉구하는 본 연구는 정책 도입에 앞서 선결되어야 할 과제로서 공중보건학적 측면에서 중요한 의의를 지닌다.
Key Message

Citations

Citations to this article as recorded by  
  • Why clinicians overtest: development of a thematic framework
    Justin H. Lam, Kristen Pickles, Fiona F. Stanaway, Katy J. L. Bell
    BMC Health Services Research.2020;[Epub]     CrossRef
Cancer screening rate in people with diabetes in the Korean population: results from the Korea National Health and Nutrition Examination Survey 2007-2009
Kumban Walter Chuck, Minji Hwang, Kui Son Choi, Mina Suh, Jae Kwan Jun, Boyoung Park
Epidemiol Health. 2017;39:e2017036.   Published online August 10, 2017
DOI: https://doi.org/10.4178/epih.e2017036
  • 10,472 View
  • 231 Download
  • 13 Citations
AbstractAbstract AbstractSummary PDF
Abstract
OBJECTIVES
To investigate the screening rates for gastric, breast, and cervical cancer in people with diabetes compared with people without diabetes.
METHODS
Data from the Korea National Health and Nutrition Examination Survey (2007-2009) were used. Cancer-free men who were 40 years old and over and cancer-free women who were 30 years old and over were included. The lifetime screening rate and regular screening rate were compared in people with and without diabetes.
RESULTS
Fewer people with diabetes than people without diabetes had ever received cancer screening (53.5 vs. 59.5%, p<0.001 for gastric cancer; 60.5 vs. 71.5%, p<0.001 for breast cancer; and 49.1 vs. 59.6%, p<0.001 for cervical cancer). Fewer people with diabetes than people without diabetes received the recommended screenings for gastric cancer (38.9 vs. 42.9%, p<0.001), breast cancer (38.8 vs. 44.6%, p<0.001), and cervical cancer (35.1 vs. 51.2%, p<0.001). In subgroup analyses according to socioeconomic factors, the lifetime and recommended screening rates were lower in the diabetic population in most socioeconomic subgroups. In the multivariate analysis adjusted for socioeconomic factors, people with diabetes showed lower lifetime screening rates for gastric and cervical cancer (odds ratio [OR], 0.8; 95% confidence interval [CI], 0.7 to 0.9 and OR, 0.7; 95% CI, 0.6 to 0.9), and lower regular screening rates for breast and cervical cancer (OR, 0.7; 95% CI, 0.6 to 0.9 and OR, 0.7; 95% CI, 0.5 to 0.9).
CONCLUSIONS
The cancer screening rate in people with diabetes was lower than in people without diabetes. Considering the higher cancer risk in people with diabetes, efforts to increase the screening rate in this high-risk population should be implemented.
Summary
Korean summary
기존의 여러 연구에서 당뇨병이 있는 사람에서 당뇨병이 없는 경우에 비해 암 발생의 위험이 증가하는 것이 확인되었다. 본 연구에서 당뇨병이 있는 사람과 없는 사람에서 암 수검률을 비교했을 때, 당뇨병이 있는 사람의 위암, 유방암, 자궁경부암의 평생 수검률과 권고안 이행 수검률은 모두 낮았다. 당뇨병 환자가 암 발생의 고위험군임을 고려하였을 때 이들을 대상으로 암 검진 수검률을 높이려는 노력이 필요하다.
Key Message

Citations

Citations to this article as recorded by  
  • Increased Breast and Colorectal Cancer Risk in Type 2 Diabetes: Awareness Among Adults With and Without Diabetes and Information Provision on Diabetes Websites
    Laura Ashley, Kathryn A Robb, Daryl B O’Connor, Rebecca Platt, Mollie Price, Olivia Robinson, Elizabeth Travis, Lorraine Lipscombe, Ramzi Ajjan, Rebecca Birch
    Annals of Behavioral Medicine.2023; 57(5): 386.     CrossRef
  • Diabetes and Cancer
    Jae Won Hong
    The Journal of Korean Diabetes.2023; 24(1): 12.     CrossRef
  • Do diabetic complications influence cancer-related events in people with type 2 diabetes? A cohort approach
    Evelyne Liuu, Pierre-Jean Saulnier, Elise Gand, Gautier Defossez, Amélie Jamet, Stéphanie Ragot, Marc Paccalin, Samy Hadjadj
    Diabetes & Metabolism.2022; 48(2): 101289.     CrossRef
  • Factors associated with adherence to colonoscopy among individuals who were positive in the preliminary screening for colorectal neoplasms
    Ji‐Bin Li, Keng‐Jian Ke, Wei‐Li Zhang, Ling‐Yan Wang, Yan‐Ping Wu, Fan Weng, Huan Tian, Zhi‐Yu Qiu, Yin Li, Shi‐Yong Lin, Mei‐Xian Ye, Qing‐Jian Ou, Cheng‐Hua Gong, Zhen‐Hai Lu, Zhi‐Zhong Pan, De‐Sen Wan, Jian‐Hong Peng, Yu‐Jing Fang
    Cancer Medicine.2022; 11(22): 4321.     CrossRef
  • Typ-2-Diabetes mellitus und gastrointestinale Krebsvorsorge
    Hans Scherübl
    Zeitschrift für Gastroenterologie.2022;[Epub]     CrossRef
  • Prediction Model for Hypertension and Diabetes Mellitus Using Korean Public Health Examination Data (2002–2017)
    Yong Whi Jeong, Yeojin Jung, Hoyeon Jeong, Ji Hye Huh, Ki-Chul Sung, Jeong-Hun Shin, Hyeon Chang Kim, Jang Young Kim, Dae Ryong Kang
    Diagnostics.2022; 12(8): 1967.     CrossRef
  • Typ-2-Diabetes mellitus und gastrointestinale Krebsvorsorge
    Hans Scherübl
    Diabetes aktuell.2022; 20(06): 287.     CrossRef
  • The Relationship between Diabetes Mellitus and Gastric Cancer and the Potential Benefits of Metformin: An Extensive Review of the Literature
    Chin-Hsiao Tseng
    Biomolecules.2021; 11(7): 1022.     CrossRef
  • Type 2 diabetes and colorectal cancer screening: Findings from the English Longitudinal Study of Ageing
    Christian von Wagner, Dorina Cadar, Ruth A Hackett, Panayotes Demakakos, Rebecca J Beeken, Stacy Cooper Bailey, Michael Wolf, Andrew Steptoe, Cristina Renzi, Sandro T Stoffel
    Journal of Medical Screening.2020; 27(1): 25.     CrossRef
  • Breast, cervical and colorectal cancer screening in adults with diabetes: a systematic review and meta-analysis
    Dominika Bhatia, Iliana C. Lega, Wei Wu, Lorraine L. Lipscombe
    Diabetologia.2020; 63(1): 34.     CrossRef
  • Review: Diabetes, Obesity, and Cancer—Pathophysiology and Clinical Implications
    Iliana C Lega, Lorraine L Lipscombe
    Endocrine Reviews.2020; 41(1): 33.     CrossRef
  • The Incidences and Characteristics of Various Cancers in Patients on Dialysis: a Korean Nationwide Study
    Soon Kil Kwon, Joung-Ho Han, Hye-Young Kim, Gilwon Kang, Minseok Kang, Yeonkook J. Kim, Jinsoo Min
    Journal of Korean Medical Science.2019;[Epub]     CrossRef
  • Diabetes and Cancer: Cancer Should Be Screened in Routine Diabetes Assessment
    Sunghwan Suh, Kwang-Won Kim
    Diabetes & Metabolism Journal.2019; 43(6): 733.     CrossRef
Cancer mortality-to-incidence ratio as an indicator of cancer management outcomes in Organization for Economic Cooperation and Development countries
Eunji Choi, Sangeun Lee, Bui Cam Nhung, Mina Suh, Boyoung Park, Jae Kwan Jun, Kui Son Choi
Epidemiol Health. 2017;39:e2017006.   Published online February 5, 2017
DOI: https://doi.org/10.4178/epih.e2017006
  • 14,647 View
  • 424 Download
  • 57 Citations
AbstractAbstract PDF
Abstract
OBJECTIVES
Assessing long-term success and efficiency is an essential part of evaluating cancer control programs. The mortality-to-incidence ratio (MIR) can serve as an insightful indicator of cancer management outcomes for individual nations. By calculating MIRs for the top five cancers in Organization for Economic Cooperation and Development (OECD) countries, the current study attempted to characterize the outcomes of national cancer management policies according to the health system ranking of each country.
METHODS
The MIRs for the five most burdensome cancers globally (lung, colorectal, prostate, stomach, and breast) were calculated for all 34 OECD countries using 2012 GLOBOCAN incidence and mortality statistics. Health system rankings reported by the World Health Organization in 2000 were updated with relevant information when possible. A linear regression model was created, using MIRs as the dependent variable and health system rankings as the independent variable.
RESULTS
The linear relationships between MIRs and health system rankings for the five cancers were significant, with coefficients of determination ranging from 49 to 75% when outliers were excluded. A clear outlier, Korea reported lower-than-predicted MIRs for stomach and colorectal cancer, reflecting its strong national cancer control policies, especially cancer screening.
CONCLUSIONS
The MIR was found to be a practical measure for evaluating the long-term success of cancer surveillance and the efficacy of cancer control programs, especially cancer screening. Extending the use of MIRs to evaluate other cancers may also prove useful.
Summary
Korean summary
Key Message

Citations

Citations to this article as recorded by  
  • Global, regional, and national trends of dementia incidence and risk factors, 1990–2019: A Global Burden of Disease study
    Abolfazl Avan, Vladimir Hachinski
    Alzheimer's & Dementia.2023; 19(4): 1281.     CrossRef
  • Improved Trends in the Mortality-to-Incidence Ratios for Liver Cancer in Countries with High Development Index and Health Expenditures
    Chang-Cheng Su, Brian-Shiian Chen, Hsin-Hung Chen, Wen-Wei Sung, Chi-Chih Wang, Ming-Chang Tsai
    Healthcare.2023; 11(2): 159.     CrossRef
  • Updated epidemiology of gastrointestinal cancers in East Asia
    Junjie Huang, Don Eliseo Lucero-Prisno, Lin Zhang, Wanghong Xu, Sunny H. Wong, Siew C. Ng, Martin C. S. Wong
    Nature Reviews Gastroenterology & Hepatology.2023;[Epub]     CrossRef
  • Peptide Self-Assembled Nanocarriers for Cancer Drug Delivery
    Vijay Bhooshan Kumar, Busra Ozguney, Anastasia Vlachou, Yu Chen, Ehud Gazit, Phanourios Tamamis
    The Journal of Physical Chemistry B.2023; 127(9): 1857.     CrossRef
  • Spatial and temporal patterns of prostate cancer burden and their association with Socio‐Demographic Index in Asia, 1990–2019
    Li‐Sha Luo, Jun‐Feng Jiang, Hang‐Hang Luan, Hao Zi, Cong Zhu, Bing‐Hui Li, Xian‐Tao Zeng
    The Prostate.2022; 82(2): 193.     CrossRef
  • Cancer of unknown primary ‐ incidence, mortality trend, and mortality‐to‐incidence ratio is associated with human development index in Central Serbia, 1999–2018: Evidence from the national cancer registry
    Aleksandra Ignjatović, Miodrag Stojanović, Zoran Milošević, Marija Anđelković Apostolović, Tamara Filipović, Nataša Rančić, Roberta Marković, Marija Topalović, Dijana Stojanović, Suzana Otašević
    European Journal of Cancer Care.2022;[Epub]     CrossRef
  • Global, regional, and national burden and quality of care index of endocarditis: the global burden of disease study 1990–2019
    Sara Momtazmanesh, Sahar Saeedi Moghaddam, Elaheh Malakan Rad, Sina Azadnajafabad, Narges Ebrahimi, Esmaeil Mohammadi, Mahtab Rouhifard, Negar Rezaei, Masoud Masinaei, Nazila Rezaei, Mohammad Keykhaei, Arya Aminorroaya, Azin Ghamari, Bagher Larijani, Fars
    European Journal of Preventive Cardiology.2022; 29(8): 1287.     CrossRef
  • Global pattern of trends in incidence, mortality, and mortality-to-incidence ratio rates related to liver cancer, 1990–2019: a longitudinal analysis based on the global burden of disease study
    Maedeh Amini, Mehdi Azizmohammad Looha, Elaheh Zarean, Mohamad Amin Pourhoseingholi
    BMC Public Health.2022;[Epub]     CrossRef
  • Mapping Cancer in Africa: A Comprehensive and Comparable Characterization of 34 Cancer Types Using Estimates From GLOBOCAN 2020
    Rajesh Sharma, Aashima, Mehak Nanda, Claudio Fronterre, Paul Sewagudde, Anna E. Ssentongo, Kelsey Yenney, Nina D. Arhin, John Oh, Forster Amponsah-Manu, Paddy Ssentongo
    Frontiers in Public Health.2022;[Epub]     CrossRef
  • Cancer in sub-Saharan Africa in 2020: a review of current estimates of the national burden, data gaps, and future needs
    Freddie Bray, D Maxwell Parkin, Freddy Gnangnon, Gontse Tshisimogo, Jean-Felix Peko, Innocent Adoubi, Mathewos Assefa, Lamin Bojang, Baffour Awuah, Moussa Koulibaly, Nathan Buziba, Anne Korir, Charles Dzamalala, Bakarou Kamate, Shyam Manraj, Josefo Ferro,
    The Lancet Oncology.2022; 23(6): 719.     CrossRef
  • Burden of type 1 diabetes mellitus in the North Africa and Middle East Region, 1990–2019; findings from the global burden of disease study
    Shahnaz Esmaeili, Sahar Saeedi Moghaddam, Nazli Namazi, Fatemeh Bandarian, Zahra Esfahani, Maryam Peimani, Sarvenaz Shahin, Ensieh Nasli-Esfahani, Isa Akbarzadeh, Ali Ghanbari, Negar Rezaei, Nazila Rezaei, Bagher Larijani, Farshad Farzadfar
    Diabetes Research and Clinical Practice.2022; 188: 109912.     CrossRef
  • Cancer incidence and mortality and risk factors in member countries of the " Belt and Road " initiative
    Baohua Wang, Fengdie He, Yanan Hu, Qiutong Wang, Dan Wang, Yuting Sha, Jing Wu
    BMC Cancer.2022;[Epub]     CrossRef
  • Geographical Differences in Kidney Cancer Outcomes of Patients Treated with Immunotherapy: A Systematic Review
    Vinicius Knackfuss Gonçalves, Fernando Sabino Marques Monteiro, Antonia Angeli Gazola, Felipe Pizzolo, Júlia Elisa Hübner, Rodrigo Pellegrini, Alessandra Borba, André P. Fay
    Kidney Cancer.2022; 6(2): 129.     CrossRef
  • Global burden of disease study at the world health organization: research methods for the most comprehensive global study of disease and underlying health policies
    Lee Smith, Jae Il Shin, Soo Young Hwang, Kalthoum Tizaoui, Elena Dragioti, Louis Jacob, Karel Kostev, Seung Won Lee, Ai Koyanagi
    Life Cycle.2022;[Epub]     CrossRef
  • Quality of care of peptic ulcer disease worldwide: A systematic analysis for the global burden of disease study 1990–2019
    Mohsen Abbasi-Kangevari, Naser Ahmadi, Nima Fattahi, Negar Rezaei, Mohammad-Reza Malekpour, Seyyed-Hadi Ghamari, Sahar Saeedi Moghaddam, Sina Azadnajafabad, Zahra Esfahani, Ali-Asghar Kolahi, Shahin Roshani, Sahba Rezazadeh-Khadem, Fateme Gorgani, Seyyed
    PLOS ONE.2022; 17(8): e0271284.     CrossRef
  • A scoping review on population-centered indicators for cancer care continuum
    Vasuki Rajaguru, Jieun Jang, Jeoung A. Kwon, Jae Hyun Kim, Jaeyong Shin, Mison Chun
    Frontiers in Public Health.2022;[Epub]     CrossRef
  • COMPARISON OF TEMPORAL TRENDS OF GLOBAL BURDEN OF TRACHEA, BRONCIHAL, AND LUNG CANCER
    İskender ÇETİNTÜRK, Vahit YİĞİT
    Giresun Üniversitesi İktisadi ve İdari Bilimler Dergisi.2022;[Epub]     CrossRef
  • ANALYSIS OF INCIDENCE AND MORTALITY OF GASTROINTESTINAL MALIGNANT TUMORS IN UKRAINE AND WORLDWIDE
    Valeriy Zub
    Acta Medica Leopoliensia.2022; 28(3-4): 22.     CrossRef
  • Global, regional, national burden of breast cancer in 185 countries: evidence from GLOBOCAN 2018
    Rajesh Sharma
    Breast Cancer Research and Treatment.2021; 187(2): 557.     CrossRef
  • A global, regional, and national survey on burden and Quality of Care Index (QCI) of hematologic malignancies; global burden of disease systematic analysis 1990–2017
    Mohammad Keykhaei, Masood Masinaei, Esmaeil Mohammadi, Sina Azadnajafabad, Negar Rezaei, Sahar Saeedi Moghaddam, Nazila Rezaei, Maryam Nasserinejad, Mohsen Abbasi-Kangevari, Mohammad-Reza Malekpour, Seyyed-Hadi Ghamari, Rosa Haghshenas, Kamyar Koliji, Far
    Experimental Hematology & Oncology.2021;[Epub]     CrossRef
  • The global landscape of drug development of trastuzumab biosimilars
    Dario Trapani, Giuseppe Curigliano
    Journal of Cancer Policy.2021; 28: 100273.     CrossRef
  • Trend analysis of cardiovascular disease mortality, incidence, and mortality-to-incidence ratio: results from global burden of disease study 2017
    Maedeh Amini, Farid Zayeri, Masoud Salehi
    BMC Public Health.2021;[Epub]     CrossRef
  • Global, regional, and national burden and quality of care index (QCI) of thyroid cancer: A systematic analysis of the Global Burden of Disease Study 1990–2017
    Sina Azadnajafabad, Sahar Saeedi Moghaddam, Esmaeil Mohammadi, Negar Rezaei, Erfan Ghasemi, Nima Fattahi, Arya Aminorroaya, Reza Azadnajafabad, Armin Aryannejad, Nazila Rezaei, Shohreh Naderimagham, Vahid Haghpanah, Ali H. Mokdad, Hossein Gharib, Farshad
    Cancer Medicine.2021; 10(7): 2496.     CrossRef
  • National and Subnational Incidence, Mortality, and Years of Life Lost Due to Breast Cancer in Iran: Trends and Age-Period-Cohort Analysis Since 1990
    Bahar Ataeinia, Sahar Saeedi Moghaddam, Mahsima Shabani, Kimiya Gohari, Ali Sheidaei, Nazila Rezaei, Shohreh Naderimagham, Erfan Ghasemi, Mahtab Rouhifard Khalilabad, Shahin Roshani, Yosef Farzi, Farshad Farzadfar
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • Honey and its protein components: Effects in the cancer immunology
    Ivan Chan‐Zapata, Maira Rubí Segura‐Campos
    Journal of Food Biochemistry.2021;[Epub]     CrossRef
  • A Comparison of the United States and Austrian Healthcare Needs and Systems
    Margaret McAlister, Joey D. Helton
    INQUIRY: The Journal of Health Care Organization, Provision, and Financing.2021; 58: 004695802110001.     CrossRef
  • Recent trend of androgen deprivation therapy in newly diagnosed prostate cancer patients: Comparing between high‐ and middle‐income Asian countries
    Jasmine Lim, Mizuki Onozawa, Marniza Saad, Teng Aik Ong, Rohan Malek, Hideyuki Akaza
    Cancer Science.2021; 112(6): 2071.     CrossRef
  • A spatial assessment of prostate cancer mortality-to-incidence ratios among South Carolina veterans: 1999–2015
    Peter Georgantopoulos, Jan M. Eberth, Bo Cai, Gowtham Rao, Charles L. Bennett, Christopher T. Emrich, Kathlyn S. Haddock, James R. Hébert
    Annals of Epidemiology.2021; 59: 24.     CrossRef
  • Assessment of quality benchmarks in adenoma detection in Mexico
    Nancy E. Aguilar-Olivos, Ricardo Balanzá, Fernando Rojas-Mendoza, Rodrigo Soto-Solis, Mario A. Ballesteros-Amozurrutia, Norma González-Uribe, Justo A. Fernández-Rivero
    Endoscopy International Open.2021; 09(06): E796.     CrossRef
  • Favorable Lip and Oral Cancer Mortality-to-Incidence Ratios in Countries with High Human Development Index and Expenditures on Health
    Wen-Wei Sung, Yong-Chen Hsu, Chen Dong, Ying-Ching Chen, Yu-Chi Chao, Chih-Jung Chen
    International Journal of Environmental Research and Public Health.2021; 18(11): 6012.     CrossRef
  • In prostatic transition zone lesions (PI-RADS v2.1): which subgroup should be biopsied?
    Jihae An, Young Joong Kim, Jae Young Seo, Cheol Mog Hwang, Dong Hyun Oh, Mu-Sik Lee, Keum Won Kim
    Egyptian Journal of Radiology and Nuclear Medicine.2021;[Epub]     CrossRef
  • Improvement in the Mortality-to-Incidence Ratios for Gastric Cancer in Developed Countries With High Health Expenditures
    Tzu-Wei Yang, Chi-Chih Wang, Wei-Cheng Hung, Yu-Hsiang Liu, Wen-Wei Sung, Ming-Chang Tsai
    Frontiers in Public Health.2021;[Epub]     CrossRef
  • Provider Barriers and Facilitators of Breast Cancer Guideline-Concordant Therapy Delivery in Botswana: A Consolidated Framework for Implementation Research Analysis
    Tlotlo Ralefala, Lebogang Mokokwe, Swetha Jammalamadugu, Dumelang Legobere, Warona S. Motlhwa, Anthony A. Oyekunle, Surbhi Grover, Frances K. Barg, Lawrence N. Shulman, Yehoda M. Martei
    The Oncologist.2021; 26(12): e2200.     CrossRef
  • Improving Quality Indicator of Melanoma Management – Change of Melanoma Mortality-to-Incidence Rate Ratio Based on a Hungarian Nationwide Retrospective Study
    Máté Várnai, Zoltán Kiss, Rolland Gyulai, Judit Oláh, Péter Holló, Gabriella Emri, András Csejtei, István Kenessey, Angéla Benedek, Zoltán Polányi, Zsófia Nagy-Erdei, Andrea Dániel, Kata Knollmajer, György Rokszin, Ibolya Fábián, Zsófia Barcza, Csaba Polg
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • Cancer survival status among male population of Northeast India: A hospital based study
    Manoj Kalita, JagannathDev Sharma, Debanjana Barman, Nizara Baishya, ChandiRam Kalita
    Annals of Oncology Research and Therapy.2021; 1(1): 28.     CrossRef
  • Global Burden of Head and Neck Cancer: Economic Consequences, Health, and the Role of Surgery
    Rolvix H. Patterson, Victoria G. Fischman, Isaac Wasserman, Jennifer Siu, Mark G. Shrime, Johannes J. Fagan, Wayne Koch, Blake C. Alkire
    Otolaryngology–Head and Neck Surgery.2020; 162(3): 296.     CrossRef
  • Trends of National and Subnational Incidence of Childhood Cancer Groups in Iran: 1990–2016
    Mahsima Shabani, Sahar Saeedi Moghaddam, Bahar Ataeinia, Nazila Rezaei, Farnam Mohebi, Bahram Mohajer, Kimiya Gohari, Ali Sheidaei, Farhad Pishgar, Moein Yoosefi, Farzad Kompani, Farshad Farzadfar
    Frontiers in Oncology.2020;[Epub]     CrossRef
  • Evaluation of the Cardiac Protection Conferred by Proanthocyanidins in Grape Seeds against Development of Ehrlich Solid Tumors in Mice
    Maha Abdulrahman Aldubayan
    BioMed Research International.2020; 2020: 1.     CrossRef
  • The economic burden of cancer care for Syrian refugees: a population-based modelling study
    Rima A Abdul-Khalek, Ping Guo, Forbes Sharp, Adrian Gheorghe, Omar Shamieh, Tezer Kutluk, Fouad Fouad, Adam Coutts, Ajay Aggarwal, Deborah Mukherji, Ghassan Abu-Sittah, Kalipso Chalkidou, Richard Sullivan
    The Lancet Oncology.2020; 21(5): 637.     CrossRef
  • Multiple Myeloma Incidence and Mortality Around the Globe; Interrelations Between Health Access and Quality, Economic Resources, and Patient Empowerment
    Heinz Ludwig, Susie Novis Durie, Angela Meckl, Axel Hinke, Brian Durie
    The Oncologist.2020; 25(9): e1406.     CrossRef
  • Descriptive epidemiology of incidence and mortality of primary liver cancer in 185 countries: evidence from GLOBOCAN 2018
    Rajesh Sharma
    Japanese Journal of Clinical Oncology.2020; 50(12): 1370.     CrossRef
  • Evaluating the Effect of Medicaid Expansion on Black/White Breast Cancer Mortality Disparities: A Difference-in-Difference Analysis
    Jason Semprini, Olufunmilayo Olopade
    JCO Global Oncology.2020; (6): 1178.     CrossRef
  • State-Level Disparity in Lung Cancer Survival in the United States
    Yu-Che Lee, Rafael A. Calderon-Candelario, Gregory E. Holt, Michael A. Campos, Mehdi Mirsaeidi
    Frontiers in Oncology.2020;[Epub]     CrossRef
  • Inequalities in the burden of female breast cancer in Brazil, 1990–2017
    Maximiliano Ribeiro Guerra, Mário Círio Nogueira, Deborah Carvalho Malta, Camila Soares Lima Côrrea, Maria de Fatima Marinho de Souza, Maria Paula Curado, Mariana Santos Felisbino-Mendes, Meghan Mooney, Mohsen Naghavi, Maria Teresa Bustamante-Teixeira
    Population Health Metrics.2020;[Epub]     CrossRef
  • Disparities in mortality‐to‐incidence ratios by race/ethnicity for female breast cancer in New York City, 2002‐2016
    Tamar B. Nobel, Charles K. Asumeng, John Jasek, Kellie C. Van Beck, Ruchi Mathur, Baozhen Qiao, Jennifer J. Brown
    Cancer Medicine.2020; 9(21): 8226.     CrossRef
  • Enhanced Cancer-targeted Drug Delivery Using Precoated Nanoparticles
    Lu Yu, Mingyu Xu, Wenwen Xu, Wei Xiao, Xue-hua Jiang, Ling Wang, Huile Gao
    Nano Letters.2020; 20(12): 8903.     CrossRef
  • Oxaliplatin-Based Intra-arterial Chemotherapy in Colo-Rectal Cancer Liver Metastases: A Review from Pharmacology to Clinical Application
    Girolamo Ranieri, Mariarita Laforgia, Patrizia Nardulli, Simona Ferraiuolo, Pasquale Molinari, Ilaria Marech, Cosmo Damiano Gadaleta
    Cancers.2019; 11(2): 141.     CrossRef
  • Melanoma prognosis in the United States: Identifying barriers for improved care
    Zachary H. Hopkins, Christopher Moreno, Ryan Carlisle, Aaron M. Secrest
    Journal of the American Academy of Dermatology.2019; 80(5): 1256.     CrossRef
  • The Coincidence Between Increasing Age, Immunosuppression, and the Incidence of Patients With Glioblastoma
    Erik Ladomersky, Denise M. Scholtens, Masha Kocherginsky, Elizabeth A. Hibler, Elizabeth T. Bartom, Sebastian Otto-Meyer, Lijie Zhai, Kristen L. Lauing, Jaehyuk Choi, Jeffrey A. Sosman, Jennifer D. Wu, Bin Zhang, Rimas V. Lukas, Derek A. Wainwright
    Frontiers in Pharmacology.2019;[Epub]     CrossRef
  • The Mortality-to-Incidence Ratio Is Not a Valid Proxy for Cancer Survival
    Libby Ellis, Aurélien Belot, Bernard Rachet, Michel P. Coleman
    Journal of Global Oncology.2019; (5): 1.     CrossRef
  • National Cancer Mortality-to-Incidence Ratio (MIR) in Iran (2005 - 2014)
    Atieh Akbari, Maryam Khayamzadeh, Reza Salmanian, Ali Ghanbari Motlagh, Gholamreza Roshandel, Maryam Nouri, Mohammad Esmaeil Akbari
    International Journal of Cancer Management.2019;[Epub]     CrossRef
  • The Association between Mortality-to-Incidence Ratios and Health Expenditures in Brain and Nervous System Cancers
    Lee, Sung, Chan, Lee, Chen, Huang, Kwan
    International Journal of Environmental Research and Public Health.2019; 16(15): 2739.     CrossRef
  • miR‐181a/b therapy in lung cancer: reality or myth?
    Cornelia Braicu, Diana Gulei, Roxana Cojocneanu, Lajos Raduly, Ancuta Jurj, Erik Knutsen, George Adrian Calin, Ioana Berindan‐Neagoe
    Molecular Oncology.2019; 13(1): 9.     CrossRef
  • Breast Cancer: Reimbursement Policies and Adoption of New Therapeutic Agents by National Health Systems
    Dario Trapani, Giuseppe Curigliano, Alexandru Eniu
    Breast Care.2019; 14(6): 373.     CrossRef
  • Epidemiology of prostate cancer in Asian countries
    Takahiro Kimura, Shin Egawa
    International Journal of Urology.2018; 25(6): 524.     CrossRef
  • Cause-of-death statistics in 2016 in the Republic of Korea
    Hyun-Young Shin, Ji-Youn Lee, Jee-Eun Kim, Seokmin Lee, Heejo Youn, Heyran Kim, Jeonghun Lee, Min Sim Park, Sun Huh
    Journal of the Korean Medical Association.2018; 61(9): 573.     CrossRef
  • Is mortality-to-incidence ratio associated with health disparity in pancreatic cancer? A cross-sectional database analysis of 57 countries
    Hsiang-Lin Lee, Cheng-Ming Peng, Cheng-Yu Huang, Shin-Yi Wu, Ming-Chang Tsai, Chi-Chih Wang, Sung-Lang Chen, Chun-Che Lin, Chien-Ning Huang, Wen-Wei Sung
    BMJ Open.2018; 8(7): e020618.     CrossRef
Reliability of Quadruplicated Serological Parameters in the Korean Genome and Epidemiology Study
Jae Jeong Yang, Ji Hyun Yang, Jimin Kim, Lisa Y. Cho, Boyoung Park, Seung Hyun Ma, Sang Hoon Song, Won-Ki Min, Sung Soo Kim, Man Suck Park, Sue K. Park
Epidemiol Health. 2011;33:e2011004.   Published online May 19, 2011
DOI: https://doi.org/10.4178/epih/e2011004
  • 12,744 View
  • 99 Download
  • 9 Citations
AbstractAbstract PDF
Abstract
OBJECTIVES

The aim of this study was to evaluate whether clinical test values from different laboratories in the Korean Genome and Epidemiology Study (KoGES) can be integrated through a statistical adjustment algorithm with appropriate intra- and inter-laboratory reliability.

METHODS

External quality control data were obtained from the Korean Society for Laboratory Medicine and quadruplicated standardized serological samples (N=3,200) were manufactured in order to check the intra- and inter-laboratory reliability for aspartic acid transaminase (AST), alanine transaminase (ALT), gamma-glutamyl transpeptidase (γ-GTP), blood urea nitrogen (BUN), creatinine, uric acid (UA), fasting blood sugar (FBS), cholesterol, and triglyceride (TG). As an index of inter- and intra-rater reliability, Pearson's correlation coefficient, intraclass correlation coefficients and kappa statistics were estimated. In addition, to detect the potential for data integration, we constructed statistical compensation models using linear regression analysis with residual analysis, and presented the R-square values.

RESULTS

All correlation coefficient values indicated good intra- and inter-laboratory reliability, which ranged from 0.842 to 1.000. Kappa coefficients were greater than 0.75 (0.75-1.00). All of the regression models based on the trial results had strong R-square values and zero sums of residuals. These results were consistent in the regression models using external quality control data.

CONCLUSION

The two laboratories in the KoGES have good intra- and inter-laboratory reliability for ten chemical test values, and data can be integrated through algorithmic statistical adjustment using regression equations.

Summary
Korean summary
Key Message

Citations

Citations to this article as recorded by  
  • Healthful Plant-Based Diet and Incidence of Type 2 Diabetes in Asian Population
    Jihye Kim, Edward Giovannucci
    Nutrients.2022; 14(15): 3078.     CrossRef
  • Urinary Sodium-to-Potassium Ratio and Incident Chronic Kidney Disease
    Young Su Joo, Hyung Woo Kim, Jong Hyun Jhee, Seung Hyeok Han, Tae-Hyun Yoo, Shin-Wook Kang, Jung Tak Park
    Mayo Clinic Proceedings.2022; 97(12): 2259.     CrossRef
  • Association between Different Types of Plant-Based Diets and Risk of Dyslipidemia: A Prospective Cohort Study
    Kyueun Lee, Hyunju Kim, Casey M. Rebholz, Jihye Kim
    Nutrients.2021; 13(1): 220.     CrossRef
  • Dietary Micronutrients and Risk of Chronic Kidney Disease: A Cohort Study with 12 Year Follow-Up
    Juyeon Lee, Kook-Hwan Oh, Sue-Kyung Park
    Nutrients.2021; 13(5): 1517.     CrossRef
  • Association between Unhealthful Plant-Based Diets and Possible Risk of Dyslipidemia
    Sujin Song, Kyueun Lee, Soim Park, Nara Shin, Hyunju Kim, Jihye Kim
    Nutrients.2021; 13(12): 4334.     CrossRef
  • Secondhand Smoke and CKD
    Jong Hyun Jhee, Young Su Joo, Youn Kyung Kee, Su-Young Jung, Seohyun Park, Chang-Yun Yoon, Seung Hyeok Han, Tae-Hyun Yoo, Shin-Wook Kang, Jung Tak Park
    Clinical Journal of the American Society of Nephrology.2019; 14(4): 515.     CrossRef
  • Association between Dietary Mineral Intake and Chronic Kidney Disease: The Health Examinees (HEXA) Study
    Jeewoo Kim, Juyeon Lee, Kyoung-Nam Kim, Kook-Hwan Oh, Curie Ahn, Jongkoo Lee, Daehee Kang, Sue Park
    International Journal of Environmental Research and Public Health.2018; 15(6): 1070.     CrossRef
  • Upper Normal Serum Creatinine Concentrations as a Predictor for Chronic Kidney Disease: Analysis of 14 Years’ Korean Genome and Epidemiology Study (KoGES)
    Jong Jhee, Seun Hwang, Joon Song, Seoung Lee
    Journal of Clinical Medicine.2018; 7(11): 463.     CrossRef
  • Dairy Product Intake Is Inversely Associated with Metabolic Syndrome in Korean Adults: Anseong and Ansan Cohort of the Korean Genome and Epidemiology Study
    Hyehyung Shin, Yeong Sook Yoon, Yoonna Lee, Cho-il Kim, Sang Woo Oh
    Journal of Korean Medical Science.2013; 28(10): 1482.     CrossRef

Epidemiol Health : Epidemiology and Health